      AYUSH

      Ayurvedic Drugs and Protocol for COVID-19
      Posted On: 18 SEP 2020 7:09PM by PIB Delhi


    A total of 247 proposals of Ayurveda interventions have been received under modified Extra Mural research (EMR) Scheme for SARS CoV-2 infection and COVID-19 disease. Out of 247 proposals, 21 research proposals recommended by competent authority on Ayurveda for SARS/COVID cases have been approved for funding.


    Ministry of AYUSH has formed an Inter-disciplinary AYUSH R&D Task Force. Task Force has formulated and designed clinical research protocols for prophylactic studies and add-on interventions in COVID-19 positive cases through thorough review and consultative process of experts of high repute from different organizations across the country for studying four different interventions viz. Ashwagandha, Yashtimadhu, Guduchi + Pippali and a poly herbal formulation (AYUSH-64). AyushSanjivani mobile app developed by Ministry of AYUSH has also been launched to generate data on acceptance and usage of AYUSH advocacies and measures among the population and its impact in prevention of COVID-19 targeting 05 million population. All these studies are at various stages of conduction.


    This information was given by the Minister of Health and Family Welfare Dr. Harsh Vardhan in a written reply in the LokSabha today.


    MV/SK

    
    
    (Release ID: 1656377) Visitor Counter : 139
    
    
      Read this release in: Telugu , Marathi , Urdu , Manipuri , Punjabi